These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17657859

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M.
    Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2008 Oct; 121(6):787-91. PubMed ID: 17869326
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
    Koitabashi Y, Ikoma M, Shibawaka T, Yamaguchi Y, Mio H, Doi K, Meguro T, Yamada K.
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC, Sherman JA, Hall AE, Simons M, Mulligan-Kehoe MJ.
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Role of Fibrinolytic System in Health and Disease.
    Kwaan HC.
    Int J Mol Sci; 2022 May 09; 23(9):. PubMed ID: 35563651
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM, Kalnoski MH, Frederick M, Chandler WL.
    Thromb Res; 2005 May 09; 115(4):327-40. PubMed ID: 15668193
    [Abstract] [Full Text] [Related]

  • 15. Plasmin system regulation in an ovalbumin-induced rat model of asthma.
    Kucharewicz I, Mogielnicki A, Kasacka I, Buczko W, Bodzenta-Łukaszyk A.
    Int Arch Allergy Immunol; 2008 May 09; 147(3):190-6. PubMed ID: 18594148
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
    Lobov S, Croucher DR, Saunders DN, Ranson M.
    Thromb Haemost; 2008 Aug 09; 100(2):319-29. PubMed ID: 18690354
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T, Bokarewa M, Zhu Y, Tarkowski A.
    Eur J Haematol; 2008 Jul 09; 81(1):8-17. PubMed ID: 18331597
    [Abstract] [Full Text] [Related]

  • 19. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
    Seth D, Hogg PJ, Gorrell MD, McCaughan GW, Haber PS.
    J Hepatol; 2008 Apr 09; 48(4):614-27. PubMed ID: 18289715
    [Abstract] [Full Text] [Related]

  • 20. Plasma fibrinolytic profile in patients with brain tumors.
    Sawaya R, Ramo OJ, Glas-Greenwalt P, Wu SZ.
    Thromb Haemost; 1991 Jan 23; 65(1):15-9. PubMed ID: 1827214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.